Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003287. Review.

PMID:
16625575
2.

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003287. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003287.

PMID:
15495047
3.

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR.

Cochrane Database Syst Rev. 2004;(2):CD003287. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003287.

PMID:
15106199
4.

Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

Fullerton B, Siebenhofer A, Jeitler K, Horvath K, Semlitsch T, Berghold A, Plank J, Pieber TR, Gerlach FM.

Cochrane Database Syst Rev. 2016 Jun 30;(6):CD012161. doi: 10.1002/14651858.CD012161. Review.

PMID:
27362975
5.

Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.

Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Review.

PMID:
26798030
6.

Intermediate acting versus long acting insulin for type 1 diabetes mellitus.

Vardi M, Jacobson E, Nini A, Bitterman H.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006297. doi: 10.1002/14651858.CD006297.pub2. Review.

PMID:
18646147
7.

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. Review.

PMID:
17443605
8.

WITHDRAWN: Inhaled insulin in diabetes mellitus.

Royle P, Waugh N, Deakin M, Philip S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003890. doi: 10.1002/14651858.CD003890.pub3. Review.

PMID:
19160227
9.

Inhaled insulin in diabetes mellitus.

Royle P, Waugh N, McAuley L, McIntyre L, Thomas S.

Cochrane Database Syst Rev. 2004;(3):CD003890. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD003890.

PMID:
15266506
10.

Inhaled insulin in diabetes mellitus.

Royle P, Waugh N, McAuley L, McIntyre L, Thomas S.

Cochrane Database Syst Rev. 2003;(3):CD003890. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003890.

PMID:
12917994
11.

Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.

Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, Pieber TR.

Arch Intern Med. 2005 Jun 27;165(12):1337-44. Review.

PMID:
15983281
12.

Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis.

Mannucci E, Monami M, Marchionni N.

Diabetes Obes Metab. 2009 Jan;11(1):53-9. doi: 10.1111/j.1463-1326.2008.00934.x. Epub 2008 Jul 29. Review.

PMID:
18671795
13.

Insulin detemir versus insulin glargine for type 2 diabetes mellitus.

Swinnen SG, Simon AC, Holleman F, Hoekstra JB, Devries JH.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD006383. doi: 10.1002/14651858.CD006383.pub2. Review.

PMID:
21735405
14.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
15.
16.

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005103. doi: 10.1002/14651858.CD005103.pub2. Review.

PMID:
20091571
17.

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

Ceglia L, Lau J, Pittas AG.

Ann Intern Med. 2006 Nov 7;145(9):665-75.

PMID:
17088580
18.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
19.

Glucagon-like peptide analogues for type 2 diabetes mellitus.

Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD006423. doi: 10.1002/14651858.CD006423.pub2. Review.

PMID:
21975753
20.

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.

Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT.

Diabetes Metab. 2011 Jun;37(3):190-200. doi: 10.1016/j.diabet.2010.12.003. Epub 2011 Feb 17. Review.

PMID:
21333580

Supplemental Content

Support Center